Daiwa Securities Group Inc. - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 49 filers reported holding HAEMONETICS CORP MASS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q4 2022$1,665
-99.9%
2,000,000
-50.0%
0.01%
-51.9%
Q3 2022$3,203,000
-46.5%
4,000,000
-47.0%
0.03%
-41.3%
Q2 2022$5,991,0007,543,0000.05%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 17,558$15,0281.36%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,406,1541.02%
ADVENT CAPITAL MANAGEMENT /DE/ 53,348,000$45,660,4170.88%
DeepCurrents Investment Group LLC 24,371,000$20,841,7960.82%
MACKAY SHIELDS LLC 29,499,000$25,204,7360.70%
SSI INVESTMENT MANAGEMENT LLC 11,208,000$9,536,8590.67%
Aequim Alternative Investments LP 20,500,000$17,545,8980.66%
Quaero Capital S.A. 900,000$769,6350.59%
READYSTATE ASSET MANAGEMENT LP 8,000,000$6,847,1800.52%
Empyrean Capital Partners, LP 12,000,000$10,215,0000.46%
View complete list of HAEMONETICS CORP MASS shareholders